Axial Biotherapeutics raises $25m in Series B financing

Image: Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Photo: courtesy of David Castillo Dominici/FreeDigitalPhotos.net.